Charurut Somboonwit, MDProfessorDivision of Infectious Diseases and International MedicineDepartment of Internal MedicineUniversity of South FloridaMorsani College of MedicineTampa, FLUSAPaul Shapshak, PhDProfessorDivision of Infectious Diseases and International MedicineDepartment of Internal MedicineUniversity of South FloridaMorsani College of MedicineTampa, FLUSAPandjassarame Kangueane, PhDDirector, Biomedical Informatics Private Ltd. PuducherryIndiaSeetharaman Balaji, PhDProfessor, Department of BiotechnologyManipal Institute of TechnologyManipal Academy of Higher EducationManipalIndiaJohn T. Sinnott, MD, FACPProfessor Division of Infectious Diseases and International MedicineDepartment of Internal MedicineUniversity of South FloridaMorsani College of MedicineTampa, FLUSALynnette Menezes, PhDProfessor of MedicineDivision of Infectious Diseases and International MedicineAssociate Vice President International, USF HealthAssociate Dean InternationalMorsani College of MedicineUniversity of South FloridaTampa, FLUSAAsa Oxner, MDVP, Associate CMO for Ambulatory Services, Tampa General HospitalMedical Director, IDEA Exchange TampaAssoc. Prof., Dept of Internal Medicine, USF Morsani College of MedicineMedical Director, IDEA Exchange TampaDepartment of Internal MedicineUniversity of South FloridaTampa, FLUSA

• .- 1. The genome sequence analysis of SARS- CoV-2 variants of concern.- 2. Influenza: Clinical challenges in the 21st century.- 3. Ebola: Virology, clinical considerations, and outbreak response and prevention.- 3. A clinical approach to novel diagnostics and therapeutics: The challenge of Zika.- .5 Oncogenic human papillomavirus.- 6. Hepatitis C virus infection in people who inject drugs.- 7. Hepatitis C: Updates in epidemiology and treatment with direct-acting antivirals.- 8. NeuroAIDS, comorbid mood disorders and neuropsychiatric effects of antiretroviral therapy.- 9. Marijuana and HIV.- 10. Mpox: An emerging global orthopoxvirus outbreak.- 11. Community-acquired respiratory infections in HCT and immunosuppressed patients.- 12. COVID-19 in cancer and hematopoietic stem cell transplant recipients.- 13. Epstein-Barr virus: Acute infection, oncogenesis, prevention and pitfalls.- 14. Human herpesvirus 6A, 6B, 7 and 8 in hematopoietic stem cell transplant: A clinical review.- 15. Cytomegalovirus infections in hematopoietic cell transplant and solid organ transplant recipients.- 16. Herpes simplex virus and varicella zoster virus in hematopoietic stem cell transplant recipients.- 17. The virology of hemophagocytic lymphohistiocytosis.- 18. Antiviral agents: Cidofovir and Brincidofovir.- 19. Antiviral agents: Ganciclovir and valganciclovir.- 20. Antiviral agents: Letermovir.- 21. Antiviral agents: Maribavir.- 22. Antiviral agents in the hematopoietic stem cell transplant population: Acyclovir, valacyclovir, penciclovir and famciclovir.- 23. Antiviral agents in the hematopoietic stem cell transplant population: Foscarnet.- 24. Radioimmunotherapy: An overview.

Charurut Somboonwit, MDProfessorDivision of Infectious Diseases and International MedicineDepartment of Internal MedicineUniversity of South FloridaMorsani College of MedicineTampa, FLUSAPaul Shapshak, PhDProfessorDivision of Infectious Diseases and International MedicineDepartment of Internal MedicineUniversity of South FloridaMorsani College of MedicineTampa, FLUSAPandjassarame Kangueane, PhDDirector, Biomedical Informatics Private Ltd. PuducherryIndiaSeetharaman Balaji, PhDProfessor, Department of BiotechnologyManipal Institute of TechnologyManipal Academy of Higher EducationManipalIndiaJohn T. Sinnott, MD, FACPProfessor Division of Infectious Diseases and International MedicineDepartment of Internal MedicineUniversity of South FloridaMorsani College of MedicineTampa, FLUSALynnette Menezes, PhDProfessor of MedicineDivision of Infectious Diseases and International MedicineAssociate Vice President International, USF HealthAssociate Dean InternationalMorsani College of MedicineUniversity of South FloridaTampa, FLUSAAsa Oxner, MDVP, Associate CMO for Ambulatory Services, Tampa General HospitalMedical Director, IDEA Exchange TampaAssoc. Prof., Dept of Internal Medicine, USF Morsani College of MedicineMedical Director, IDEA Exchange TampaDepartment of Internal MedicineUniversity of South FloridaTampa, FLUSA

• .- 1. The genome sequence analysis of SARS- CoV-2 variants of concern.- 2. Influenza: Clinical challenges in the 21st century.- 3. Ebola: Virology, clinical considerations, and outbreak response and prevention.- 3. A clinical approach to novel diagnostics and therapeutics: The challenge of Zika.- .5 Oncogenic human papillomavirus.- 6. Hepatitis C virus infection in people who inject drugs.- 7. Hepatitis C: Updates in epidemiology and treatment with direct-acting antivirals.- 8. NeuroAIDS, comorbid mood disorders and neuropsychiatric effects of antiretroviral therapy.- 9. Marijuana and HIV.- 10. Mpox: An emerging global orthopoxvirus outbreak.- 11. Community-acquired respiratory infections in HCT and immunosuppressed patients.- 12. COVID-19 in cancer and hematopoietic stem cell transplant recipients.- 13. Epstein-Barr virus: Acute infection, oncogenesis, prevention and pitfalls.- 14. Human herpesvirus 6A, 6B, 7 and 8 in hematopoietic stem cell transplant: A clinical review.- 15. Cytomegalovirus infections in hematopoietic cell transplant and solid organ transplant recipients.- 16. Herpes simplex virus and varicella zoster virus in hematopoietic stem cell transplant recipients.- 17. The virology of hemophagocytic lymphohistiocytosis.- 18. Antiviral agents: Cidofovir and Brincidofovir.- 19. Antiviral agents: Ganciclovir and valganciclovir.- 20. Antiviral agents: Letermovir.- 21. Antiviral agents: Maribavir.- 22. Antiviral agents in the hematopoietic stem cell transplant population: Acyclovir, valacyclovir, penciclovir and famciclovir.- 23. Antiviral agents in the hematopoietic stem cell transplant population: Foscarnet.- 24. Radioimmunotherapy: An overview.

Charurut Somboonwit, MDProfessorDivision of Infectious Diseases and International MedicineDepartment of Internal MedicineUniversity of South FloridaMorsani College of MedicineTampa, FLUSAPaul Shapshak, PhDProfessorDivision of Infectious Diseases and International MedicineDepartment of Internal MedicineUniversity of South FloridaMorsani College of MedicineTampa, FLUSAPandjassarame Kangueane, PhDDirector, Biomedical Informatics Private Ltd. PuducherryIndiaSeetharaman Balaji, PhDProfessor, Department of BiotechnologyManipal Institute of TechnologyManipal Academy of Higher EducationManipalIndiaJohn T. Sinnott, MD, FACPProfessor Division of Infectious Diseases and International MedicineDepartment of Internal MedicineUniversity of South FloridaMorsani College of MedicineTampa, FLUSALynnette Menezes, PhDProfessor of MedicineDivision of Infectious Diseases and International MedicineAssociate Vice President International, USF HealthAssociate Dean InternationalMorsani College of MedicineUniversity of South FloridaTampa, FLUSAAsa Oxner, MDVP, Associate CMO for Ambulatory Services, Tampa General HospitalMedical Director, IDEA Exchange TampaAssoc. Prof., Dept of Internal Medicine, USF Morsani College of MedicineMedical Director, IDEA Exchange TampaDepartment of Internal MedicineUniversity of South FloridaTampa, FLUSA

• .- 1. The genome sequence analysis of SARS- CoV-2 variants of concern.- 2. Influenza: Clinical challenges in the 21st century.- 3. Ebola: Virology, clinical considerations, and outbreak response and prevention.- 3. A clinical approach to novel diagnostics and therapeutics: The challenge of Zika.- .5 Oncogenic human papillomavirus.- 6. Hepatitis C virus infection in people who inject drugs.- 7. Hepatitis C: Updates in epidemiology and treatment with direct-acting antivirals.- 8. NeuroAIDS, comorbid mood disorders and neuropsychiatric effects of antiretroviral therapy.- 9. Marijuana and HIV.- 10. Mpox: An emerging global orthopoxvirus outbreak.- 11. Community-acquired respiratory infections in HCT and immunosuppressed patients.- 12. COVID-19 in cancer and hematopoietic stem cell transplant recipients.- 13. Epstein-Barr virus: Acute infection, oncogenesis, prevention and pitfalls.- 14. Human herpesvirus 6A, 6B, 7 and 8 in hematopoietic stem cell transplant: A clinical review.- 15. Cytomegalovirus infections in hematopoietic cell transplant and solid organ transplant recipients.- 16. Herpes simplex virus and varicella zoster virus in hematopoietic stem cell transplant recipients.- 17. The virology of hemophagocytic lymphohistiocytosis.- 18. Antiviral agents: Cidofovir and Brincidofovir.- 19. Antiviral agents: Ganciclovir and valganciclovir.- 20. Antiviral agents: Letermovir.- 21. Antiviral agents: Maribavir.- 22. Antiviral agents in the hematopoietic stem cell transplant population: Acyclovir, valacyclovir, penciclovir and famciclovir.- 23. Antiviral agents in the hematopoietic stem cell transplant population: Foscarnet.- 24. Radioimmunotherapy: An overview.